HELD FOR SALE AND DISCONTINUED OPERATIONS (Tables)

12 Months Ended

Dec. 31, 2012

Held for Sale and Discontinued Operations [Abstract]

Summarized Financial Information for Discontinued Operations

Summarized financial information for the discontinued operations is set forth below:

	2012			2011			2010
Net revenues	$	116,940		$	118,557		$	108,805
Income (loss) from discontinued operations before taxes	(73,741		)	7,072			9,328
Income tax expense (benefit)	623			(4,486		)	(2,832		)
Income (loss) from discontinued operations, net of taxes	$	(74,364	)	$	11,558		$	12,160

Schedule of Assets Held for Sale and Liabilities Related to Assets Held for Sale [Table Text Block]

The following table summarizes the HemoCue assets and liabilities held for sale in our consolidated balance sheets at December 31, 2012.

	2012
Assets held for sale:
Cash and cash equivalents	$	17,234
Accounts receivable, net	14,430
Inventories	5,388
Deferred income taxes	242
Prepaid expenses and other current assets	2,898
Total current assets held for sale	$	40,192
Property, plant and equipment, net	$	24,782
Goodwill	218,795
Intangible assets, net	110,773
Other assets	34
Total non-current assets held for sale	$	354,384
Liabilities held for sale:
Accounts payable and accrued expenses	$	21,322
Short-term borrowings and current portion of long-term debt	449
Deferred income taxes	237
Total current liabilities held for sale	$	22,008
Long-term debt	$	16,221
Other liabilities	44,579
Total non-current liabilities held for sale	$	60,800